HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bao-Guo Xiao Selected Research

ginkgolide K

1/2022The neuroprotective effects and transdifferentiation of astrocytes into dopaminergic neurons of Ginkgolide K on Parkinson' disease mice.
1/2021Eomesodermin in CD4+T cells is essential for Ginkgolide K ameliorating disease progression in experimental autoimmune encephalomyelitis.
10/2019Ginkgolide K supports remyelination via induction of astrocytic IGF/PI3K/Nrf2 axis.
5/2019The therapeutic potential of ginkgolide K in experimental autoimmune encephalomyelitis via peripheral immunomodulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bao-Guo Xiao Research Topics

Disease

28Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2023 - 08/2004
17Demyelinating Diseases (Demyelinating Disease)
01/2024 - 06/2010
16Multiple Sclerosis
01/2024 - 06/2003
12Inflammation (Inflammations)
01/2024 - 04/2002
11Neuroinflammatory Diseases
10/2023 - 05/2011
8Neurodegenerative Diseases (Neurodegenerative Disease)
04/2023 - 05/2012
8Autoimmune Diseases (Autoimmune Disease)
02/2008 - 01/2003
7Parkinson Disease (Parkinson's Disease)
04/2023 - 01/2017
6Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis)
01/2019 - 12/2002
5Hypoxia (Hypoxemia)
01/2017 - 01/2009
4Alzheimer Disease (Alzheimer's Disease)
05/2023 - 01/2017
4Stroke (Strokes)
01/2022 - 05/2007
4Nervous System Diseases (Neurological Disorders)
11/2018 - 11/2007
4Neoplasms (Cancer)
11/2018 - 01/2003
4Body Weight (Weight, Body)
01/2018 - 03/2003
4Myasthenia Gravis
06/2012 - 08/2004
4Brain Ischemia (Cerebral Ischemia)
11/2007 - 04/2002
3Necrosis
11/2018 - 08/2005
2Disease Progression
01/2021 - 11/2012
2Atrophy
01/2019 - 01/2019
2Weight Loss (Weight Reduction)
01/2012 - 12/2011
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2003 - 04/2002
1Wounds and Injuries (Trauma)
01/2023
1Infertility (Sterility)
12/2022
1Ischemic Stroke
01/2022
1Pyelonephritis
07/2019
1Atherosclerosis
01/2019
1Memory Disorders (Memory Loss)
01/2017
1Parkinsonian Disorders (Parkinsonism)
12/2016
1Movement Disorders (Movement Disorder)
12/2016

Drug/Important Bio-Agent (IBA)

24fasudil (AT 877)IBA
11/2023 - 11/2009
13rho-Associated KinasesIBA
12/2022 - 02/2010
11CuprizoneIBA
01/2024 - 01/2019
10Therapeutic UsesIBA
12/2022 - 08/2004
8Neuroprotective AgentsIBA
01/2022 - 05/2007
7CytokinesIBA
05/2023 - 01/2003
5Myelin Basic ProteinIBA
01/2024 - 08/2005
5wuzi yanzongIBA
10/2023 - 01/2022
51- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2023 - 12/2016
5Cholinergic ReceptorsIBA
02/2008 - 03/2003
4ginkgolide KIBA
01/2022 - 05/2019
4AutoantibodiesIBA
01/2022 - 08/2004
4Myelin-Oligodendrocyte GlycoproteinIBA
01/2019 - 06/2010
4AntibodiesIBA
08/2004 - 12/2002
3hydroxyfasudilIBA
11/2023 - 01/2019
3bilobalideIBA
08/2022 - 01/2019
3Interleukin-6 (Interleukin 6)IBA
12/2019 - 05/2011
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2019 - 01/2017
3Interleukin-10 (Interleukin 10)IBA
09/2007 - 01/2005
3Peptides (Polypeptides)IBA
08/2007 - 01/2003
2Black-GoldIBA
01/2024 - 01/2020
2LipopolysaccharidesIBA
01/2024 - 08/2023
2Luxol Fast Blue MBS (Luxol fast blue)IBA
12/2022 - 01/2020
2Proteins (Proteins, Gene)FDA Link
12/2022 - 01/2017
2NF-kappa B (NF-kB)IBA
12/2019 - 10/2019
2Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2019 - 02/2008
2InterleukinsIBA
11/2018 - 08/2005
2CannabinoidsIBA
01/2018 - 12/2011
2RimonabantIBA
01/2018 - 01/2012
2Oxygen (Dioxygen)IBA
01/2017 - 11/2009
2Glucose (Dextrose)FDA LinkGeneric
01/2017 - 11/2009
2CB1 Cannabinoid Receptor (CB1 Receptor)IBA
02/2016 - 01/2012
2EndocannabinoidsIBA
01/2012 - 12/2011
2LigandsIBA
05/2011 - 08/2005
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2007 - 05/2007
2Interleukin-4 (Interleukin 4)IBA
09/2007 - 06/2003
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2007 - 06/2003
2Transforming Growth Factor beta (TGF-beta)IBA
01/2005 - 11/2004
2Estrogens (Estrogen)FDA Link
11/2004 - 09/2004
1icariinIBA
01/2024
1InflammasomesIBA
10/2023
1Conditioned Culture MediaIBA
08/2023
1Grape Seed ExtractIBA
05/2023
1Dopamine (Intropin)FDA LinkGeneric
01/2023
1GinkgolidesIBA
01/2022
1MeglumineFDA Link
01/2022
1DiterpenesIBA
01/2022
1SynucleinsIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1ethyl pyruvateIBA
01/2021
1Nerve Growth Factor (NGF)IBA
01/2020
1Ciliary Neurotrophic Factor (CNTF)IBA
01/2020
1Platelet Activating FactorIBA
05/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1myelin oligodendrocyte glycoprotein (35-55)IBA
01/2019
1Nerve Growth Factors (Neurotrophins)IBA
01/2019
1Phosphatidylinositols (Phosphatidylinositol)IBA
11/2018
1AntioxidantsIBA
11/2018
1GraphiteIBA
01/2018
1Amyloid (Amyloid Fibrils)IBA
01/2017
1tau Proteins (tau Protein)IBA
01/2017
1Presenilin-1IBA
01/2017
1EnzymesIBA
01/2017
1Small Interfering RNA (siRNA)IBA
12/2016
1Free RadicalsIBA
03/2016

Therapy/Procedure

11Therapeutics
01/2022 - 01/2003
5Immunomodulation
01/2024 - 11/2007
5Immunotherapy
08/2004 - 01/2003
1Intraperitoneal Injections
01/2019
1Communication Aids for Disabled (TDD)
01/2019